A Retrospective Single-Center Study of Ferric Derisomaltose in Adolescent Patients.

Several intravenous (IV) iron formulations are used in adolescents for the treatment of iron deficiency anemia (IDA) and iron deficiency (ID). Ferric derisomaltose (FDI) is a formulation that has not been well studied. This study reports retrospective real-world use and response in adolescent patients at a single tertiary hospital receiving IV FDI. There were 36 total infusions studied, with two infusion reactions and no cases of anaphylaxis. There was an average increase of 3.0 g/dL hemoglobin in patients with IDA and 224.7 g/L in ferritin for ID patients. Our data suggest a similar tolerance and response to that of adults.